Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate for Eosinophilic Esophagitis
NCT02113267Phase 2Terminated
- Start
- Apr 2014
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mometasone furoate nasal spray in eosinophilic esophagitis (EoE). Started Apr 2014; status: terminated.
02
Drugs
mometasone furoate nasal spray
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT02113267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113267.